Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease

被引：0
|
作者：
Audrey Benyamine
Xavier Heim
Noémie Resseguier
Daniel Bertin
Carine Gomez
Mikaël Ebbo
Jean-Robert Harlé
Gilles Kaplanski
Pascal Rossi
Nathalie Bardin
Brigitte Granel
机构：
[1] APHM,CHU Nord, Internal Medicine Department, North hospital of Marseilles
[2] Aix Marseille Univ,CHU Conception, Immunology Laboratory
[3] INSERM,CHU Timone, Epidemiology and Health Economics Unit
[4] INRA,CHU Nord, Pneumology Department
[5] C2VN,CHU Timone, Internal Medicine Department
[6] APHM,CHU Conception, Internal Medicine Department
[7] APHM,undefined
[8] Aix-Marseille University (AMU),undefined
[9] Faculty of Medicine,undefined
[10] APHM,undefined
[11] APHM,undefined
[12] APHM,undefined
来源：
Rheumatology International | 2018年 / 38卷
关键词：
Krebs von den Lungen-6; Systemic sclerosis; Lung fibrosis; Disease severity; Anti-topoisomerase 1 antibody (Scl70);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：813 / 819
页数：6
相关论文
共 50 条
  • [41] Serum Krebs von den Lungen-6 (KL-6) level as a prognostic biomarker in patients with interstitial lung abnormalities (ILA)
    Park, Hye Kyeong
    Yoon, Young-Soon
    Song, Jae-Uk
    Kang, Hyung Koo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [42] Changes in blood Krebs von den Lungen-6 predict the mortality of patients with acute exacerbation of interstitial lung disease
    Myeong Geun Choi
    Sun Mi Choi
    Jae Ha Lee
    Jung-Ki Yoon
    Jin Woo Song
    Scientific Reports, 12
  • [43] Changes in blood Krebs von den Lungen-6 predict the mortality of patients with acute exacerbation of interstitial lung disease
    Choi, Myeong Geun
    Choi, Sun Mi
    Lee, Jae Ha
    Yoon, Jung-Ki
    Song, Jin Woo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [44] Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Kuwana, Masataka
    Li, Ning
    Roth, Michael D.
    Charles, Julio
    Hant, Faye N.
    Bogatkevich, Galina S.
    Akter, Tanjina
    Kim, Grace
    Goldin, Jonathan
    Khanna, Dinesh
    Clements, Philip J.
    Furst, Daniel E.
    Elashoff, Robert M.
    Silver, Richard M.
    Assassi, Shervin
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (12) : 2059 - 2067
  • [45] Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases
    Saeed, Zainab H.
    Magdy, Mohammed H.
    Abdelnaem, Emad A.
    Mahmoud, Madyan M.
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2020, 14 (01)
  • [46] Serum Krebs von den Lungen-6 and lung ultrasound B lines as potential diagnostic and prognostic factors for rheumatoid arthritis–associated interstitial lung disease
    Dina S. Fotoh
    Asrar Helal
    Mohamed S. Rizk
    Heba A. Esaily
    Clinical Rheumatology, 2021, 40 : 2689 - 2697
  • [47] Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases
    Zainab H. Saeed
    Mohammed H. Magdy
    Emad A. Abdelnaem
    Madyan M. Mahmoud
    The Egyptian Journal of Bronchology, 2020, 14
  • [48] Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis
    Mostafa, Amira Ismail
    Salem, Ayman Elsayed
    Ahmed, Heba Allah Moussa
    Bayoumi, Aml Ibrahim
    Halim, Radwa M. Abdel
    Samie, Rasha M. Abdel
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2021, 84 (03) : 200 - 208
  • [49] Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer
    Tomita, Masaki
    Ayabe, Takanori
    Chosa, Eiichi
    Nose, Naohiro
    Nakamura, Kunihide
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2016, 64 (11) : 657 - 661
  • [50] Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer
    Masaki Tomita
    Takanori Ayabe
    Eiichi Chosa
    Naohiro Nose
    Kunihide Nakamura
    General Thoracic and Cardiovascular Surgery, 2016, 64 : 657 - 661
12345